Navigation Links
Henry Schein To Present At The 32nd Annual J.P. Morgan Healthcare Conference
Date:12/20/2013

MELVILLE, N.Y., Dec. 20, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Steven Paladino, Executive Vice President and Chief Financial Officer for Henry Schein, will present at the 32nd Annual J.P. Morgan Healthcare Conference taking place at the Westin St. Francis Hotel in San Francisco.  

Henry Schein's presentation is scheduled to begin at 4:30 p.m. PT/7:30 p.m. ET on Wednesday, January 15, 2014 and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."  A replay will be available on the Web site following the presentation.

About Henry Schein, Inc.

Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners.  The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.  A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs nearly 16,000 Team Schein Members and serves nearly 800,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items.

The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries.  The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17% since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE Henry Schein, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Ford Hospital Implants New Defibrillator for People at Risk of Sudden Cardiac Arrest
2. Henry Schein Announces $300 Million Increase To Share Repurchase Plan
3. Henry Ford Hospital Performs First Minimally Invasive Laser Brain Surgeries in Michigan
4. Henry Schein Signs Agreement To Invest In BioHorizons
5. Henry Schein To Present At Five Investor Events In November And December
6. Henry Schein MicroMD EMR Achieves 2014 Edition Complete Health IT Certification From ICSA Labs
7. Henry Schein Animal Health Launches Its First Veterinary Orthopedic Instrument Catalog
8. Henry Schein "Back to School Program" Focuses on Helping Children Start the New Year With Confidence and Motivation to Succeed
9. Henry Schein Chairman Of The Board & CEO Receives Centennial Recognition Award For Extraordinary Commitment To The National Dental Association
10. Henry Schein to Open NASDAQ Stock Market to Celebrate Rebranding of U.S. Animal Health Business
11. Henry Schein To Webcast Second Quarter 2013 Conference Call On Tuesday, August 6 At 10:00 a.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... DALLAS , April 18, 2017 Viverae ... proud to announce the integration of IBM ® ... platform to deliver targeted communications for a personalized experience. ... meaningful actions on their health in real time. The ... that matter most to members, wherever they are in ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical ... ("Precision Lens"), today announced the signing of a ... Precision Lens will deploy a dedicated sales team ... in the U.S., primarily focused in 13 states ...
(Date:4/18/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company founded ... infections, will present preclinical data supporting the use of ... (MDR) Gram-negative infections at the 27th European Congress of ... in Vienna, Austria . ... "Our ongoing preclinical ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, a pre-clinical stage ... the treatment of Acute Ischemic Stroke (AIS), today announced it has appointed Creganna ... advances towards regulatory and clinical phases. , "This is another important step for ...
(Date:4/23/2017)... ... April 23, 2017 , ... ... services announced the achievement of Cisco Select certification and SMB specialization. Altura ... States. , In earning the Select Certification, Altura fulfilled the training ...
(Date:4/22/2017)... , ... April 22, 2017 , ... ... that U.S. consumers can save an average of 70% when buying medication online ... to 97%) are available when purchasing from other countries. The report (chart below) ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in the ... which reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, ... used to remove decayed dental matter, and that teeth were then filled with bitumen, ...
Breaking Medicine News(10 mins):